~~<i id='8516A68EA4'><strike id='8516A68EA4'><tt id='8516A68EA4'><pre id='8516A68EA4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

knowledge

author：hotspot 2025-09-27 12:48:13 - browse：52464

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： ASCO Takeaways: Winners, snoozers, and the art of cancer care

leisure time

focus

hotspot

entertainment

explore

hotspot

AdobeAfederaljudgeorderedWednesdaythatNovantHealthcanmoveforwardwithitsplantobuytwoNorthCarolinahosp

WSS

Type 2 diabetes prevention programs work at large scale: study

Congress needs to close a vaccine

Data don't support strong claims for Covid

Weight loss drugs should be covered by insurers, AMA says

Experimental asthma app from Apple and Anthem shows promise

FTC loses bid to block Novant's North Carolina hospital merger

hotspot

knowledge

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

NIH chief: government has fallen behind pharma on clinical trials

Apple is now the first public company to be valued at $3 trillion

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

In age of alternative facts, a scholarly course on calling out crap

What health policies could hitch a ride on a spending bill?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Experimental asthma app from Apple and Anthem shows promise

Drug repurposing or repositioning? The language matters

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

focus

How state and local governments are sidelining science

Fight over Supreme Court dialysis ruling puts kidney patients at risk

How CO2 helps viruses stay alive longer in the air

Healthy food access boosts outcomes in two studies

Weight loss drugs should be covered by insurers, AMA says

ASCO Takeaways: Winners, snoozers, and the art of cancer care

hotspot

entertainment

explore

hotspot